{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"25"}]}],"title":"Discouraged Feelings Frequency"},{"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"13"}]}],"title":"Discouraged Feelings Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"18"}]}],"title":"Discouraged Feelings Interference"},{"categories":[{"measurements":[{"groupId":"OG000","value":"96"},{"groupId":"OG001","value":"84"}]}],"title":"Mouth Sores Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"63"},{"groupId":"OG001","value":"82"}]}],"title":"Mouth Sores Interference"},{"categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"14"}]}],"title":"Hair Loss Presence"},{"categories":[{"measurements":[{"groupId":"OG000","value":"116"},{"groupId":"OG001","value":"80"}]}],"title":"Difficulty Swallowing Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"15"}]}],"title":"Vomiting Frequency"},{"categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"17"}]}],"title":"Vomiting Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"22"}]}],"title":"Heartburn Frequency"},{"categories":[{"measurements":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"11"}]}],"title":"Heartburn Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"61"}]}],"title":"Fatigue Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"77"},{"groupId":"OG001","value":"69"}]}],"title":"Fatigue Interference"},{"categories":[{"measurements":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"32"}]}],"title":"Constipation Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"46"},{"groupId":"OG001","value":"57"}]}],"title":"Skin Radiation Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"7"}]}],"title":"Ringing In Ears Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"56"},{"groupId":"OG001","value":"38"}]}],"title":"Nausea Frequency"},{"categories":[{"measurements":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"26"}]}],"title":"Nausea Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"15"}]}],"title":"Itching Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"28"}]}],"title":"Dry Skin Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"75"},{"groupId":"OG001","value":"78"}]}],"title":"Decreased Appetite Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"53"}]}],"title":"Decreased Appetite Interference"},{"categories":[{"measurements":[{"groupId":"OG000","value":"168"},{"groupId":"OG001","value":"160"}]}],"title":"Dry Mouth Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"50"}]}],"title":"Hoarseness Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"142"},{"groupId":"OG001","value":"113"}]}],"title":"Pain Frequency"},{"categories":[{"measurements":[{"groupId":"OG000","value":"98"},{"groupId":"OG001","value":"64"}]}],"title":"Pain Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"64"},{"groupId":"OG001","value":"53"}]}],"title":"Pain Interference"},{"categories":[{"measurements":[{"groupId":"OG000","value":"159"},{"groupId":"OG001","value":"148"}]}],"title":"Taste Change Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"12"}]}],"title":"Diarrhea Frequency"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}],"title":"Nail Loss Presence"},{"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"20"}]}],"title":"Acne Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"6"}]}],"title":"Numbness And Tingling Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"3"}]}],"title":"Numbness And Tingling Interference"},{"categories":[{"measurements":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"15"}]}],"title":"Cough Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"11"}]}],"title":"Cough Interference"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}],"title":"Rash Presence"},{"categories":[{"measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"36"}]}],"title":"Anxiety Frequency"},{"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"20"}]}],"title":"Anxiety Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"17"}]}],"title":"Anxiety Interference"},{"categories":[{"measurements":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"38"}]}],"title":"Insomnia Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"45"},{"groupId":"OG001","value":"31"}]}],"title":"Insomnia Interference"},{"categories":[{"measurements":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"30"}]}],"title":"Sad Feelings Frequency"},{"categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"15"}]}],"title":"Sad Feelings Severity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"17"}]}],"title":"Sad Feelings Interference"}],"denoms":[{"counts":[{"groupId":"OG000","value":"176"},{"groupId":"OG001","value":"172"}],"units":"Participants"}],"description":"PRO-CTCAE is a patient-reported outcome (PRO) measurement system developed to evaluate symptomatic toxicity in patients on cancer clinical trials, asking the patient about experience over the last seven days. Scores may reflect worst severity of the symptom (0=None, 1=Mild, 2=Moderate, 3=Severe, and 4=Very severe), frequency of the symptom (0=Never, 1=Rarely, 2=Occasionally, 3=Frequently, 4=Almost constantly), or the symptom's interference with one's \"usual or daily activities\" (0=Not at all, 1=A little bit, 2=Somewhat, 3=Quite a bit, 4=Very much). The symptom row title will indicate \"Severity\", \"Frequency\", or \"Interference\". All scores are compared between arms; statistical analysis results are entered for p-values \\< 0.05.","groups":[{"description":"Intensity-modulated radiotherapy (IMRT) with concurrent cisplatin\n\nCisplatin: 100 mg/m2 IV on days 1 and 22 of IMRT\n\nIMRT: 35 fractions over 6 weeks, 6 fractions per week, 2 Gray per fraction to total dose of 70 Gy.","id":"OG000","title":"IMRT + Cisplatin"},{"description":"Intensity-modulated radiotherapy (IMRT) with concurrent cetuximab\n\nCetuximab: 400 mg/m2 IV 5-7 days before IMRT then 250 mg/m2 IV weekly for 7 weeks\n\nIMRT: 35 fractions over 6 weeks, 6 fractions per week, 2 Gray per fraction to total dose of 70 Gy.","id":"OG001","title":"IMRT + Cetuximab"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Eligible participants enrolled in the QOL substudy who received protocol treatment and had data.","reportingStatus":"POSTED","timeFrame":"End of treatment (approximately 6 weeks after baseline); and 3, 6, and 12 months after end of treatment (approximately 4.5, 7.5, and 13.5 months after baseline).","title":"Number of Participants With Post-baseline Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Head and Neck (PRO-CTCAE H&N) Scores >= 3","type":"SECONDARY","unitOfMeasure":"Participants"}